Confectioners
Shree Renuka Sugars Limited (NSE: RENUKA) gains 5% intraday
Shree Renuka Sugars Limited (NSE: RENUKA) stock price moves up by 5% intraday to ₹23.27, showing a breakdown trend..
Shree Renuka Sugars Limited (RENUKA) gained +5% to move higher intraday, reaching ₹23.27 on the NSE on 01 Jul 2026. The move comes as the company submitted the Exchange a copy of the Scrutinizer’s Report of Postal Ballot and informed the Exchange regarding voting results. Despite today’s gains, the stock remains in a consolidation phase, with the 6M trendline status shifting from CONSOLIDATING DOWN to CONSOLIDATION. This indicates that while there is upward movement, the stock has not yet cleared resistance levels. In the confectioners sector, RENUKA’s move appears to be more company-specific rather than a sector-wide momentum.
Technical setup — trendlines & DMA
Currently, the 6M support floor for RENUKA is at ₹20.04, which is 13.88% below today’s price, providing a buffer against further downside. Resistance remains at ₹31.16, which is 33.91% above the current price, indicating that RENUKA has room to run if it can break through this level. The 50-DMA at ₹24.8 is above the 200-DMA at ₹26.2, suggesting a bearish trend, but the stock is currently trading below both moving averages, highlighting its weak position. Within the 52W range of ₹21.1 to ₹34.1, RENUKA is in the lower third, suggesting that while there is some upside potential, a significant portion of the move may already be priced in.
Snapshot: ₹23.27 on 2026-07-01 (chart frozen at publication)
Fundamentals & business context
With a PE of n/a and profit margins at -8.6%, RENUKA’s valuation appears stretched relative to its current earnings, especially given the minimal revenue CAGR of 0.6%. This suggests that the market may be pricing in a potential turnaround, though the current financials do not support such optimism. Institutional ownership stands at 10.1%, indicating a cautious approach by smart money, likely due to the company’s recent loss in the last quarter and thin profit margins. There was no specific NSE catalyst today beyond the corporate announcement, which did not provide any new fundamental insights.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically moderate but fundamentally weak position for RENUKA. Two of the strongest signals are the very low debt level, with a D/E ratio of 0.00, indicating excellent financial health, and the bullish sentiment over the last 30 days, where up days saw significantly higher volume than down days, suggesting systematic accumulation. On the weaker side, the company’s profit margin of -8.6% leaves little room for error, and the negligible dividend yield of 0% offers little to no income for investors. These factors highlight the risks associated with RENUKA’s current valuation and financial performance.
Get all details on RENUKA — P&L, peers, shareholding and more on TradeAlone.
BALRAMCHIN
Balrampur Chini Mills Limited (balramchin) Wins ₹75 Crore Bioe3 Grant
Balrampur Chini Mills Limited (BALRAMCHIN) receives ₹75 crore BioE3 grant to advance India’s bioeconomy, boosting biomanufacturing capabilities.
Balrampur Chini Mills Limited (BCML) has been awarded ₹75 crore in grant assistance by the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology (DBT), Government of India, for establishing a 100 TPA PLA Co-Polymer R&D Facility under the Government’s flagship BioE3 initiative. The grant will accelerate the development of advanced bio-based materials, strengthen India’s indigenous biomanufacturing capabilities and reinforce the country’s ambition to emerge as a global bioeconomy powerhouse.
Strategic Move for Bioeconomy
The pilot-scale R&D facility will be established at BCML’s integrated manufacturing complex in Kumbhi, Uttar Pradesh, where the company is also setting up India’s first integrated commercial PLA manufacturing facility. The new facility will serve as the innovation engine for developing next-generation PLA grades and Co-polymers, enabling rapid product development, technology indigenisation, customer validation, and seamless scale-up to commercial production.
Government Support
Commenting on the announcement, Avantika Saraogi, Executive Director, Balrampur Chini Mills Limited, said, ‘The Government of India’s support through this ₹75 crore BioE3 grant is a strong endorsement of the strategic role that advanced biomanufacturing will play in India’s future. This facility will help build indigenous technology, develop next-generation bio-based materials, and create the scientific and technical capabilities required for India to lead the global transition towards sustainable manufacturing. We are grateful to the Department of Biotechnology and BIRAC for their confidence in our vision and look forward to contributing to India’s emergence as a global bioeconomy powerhouse.’
As countries around the world increasingly adopt bio-based materials and circular manufacturing practices, BCML’s PLA Co-Polymer R&D Facility is expected to play an important role in strengthening India’s innovation ecosystem, accelerating the commercialisation of advanced biopolymers, and positioning the country as a global hub for sustainable materials.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Balrampur Chini Mills Limited
Balrampur Chini Mills Limited belongs to the Consumer Defensive › Confectioners sector. Here’s a quick read on where the business and the stock stand today.
Balrampur gains 26.6% over three months and trades near its 52-week highs. The PEG reaches 3.72. The stock trades on brand and index weight, not on growth. Thin margins at 5.8% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock trades at 73% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The stock rises 26.6% in three months on 10.4% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Balrampur Chini Mills Limited.
Confectioners
Shree Renuka Sugars Limited (NSE: RENUKA) gains 5% intraday
Shree Renuka Sugars Limited (NSE: RENUKA) stock moves up 5% intraday to ₹23.09, despite trendline status showing a breakdown.
Shree Renuka Sugars Limited (RENUKA) gained +5% today, driven by a technical breakout above the key resistance level of ₹22. This move comes as the stock has been in a breakout trend, though it remains in the lower third of its 52-week range. Renuka Sugars, a player in the consumer defensive sector under confectioners, saw its stock price rise despite the sector not showing strong momentum, indicating this move may be more company-specific than sector-driven.
Technical setup — trendlines & DMA
From a technical standpoint, Renuka Sugars is currently trading above its 6-month support trendline, which ends at ₹21.29, indicating a 7.80% buffer from this support level. The stock has also broken through the 6-month resistance trendline, which was at ₹21.74, signaling a potential shift in momentum. However, the 50-day moving average (DMA) at ₹22.5 is below the 200-DMA at ₹24.9, suggesting a bearish trend in the longer term. The stock’s position within its 52-week range, from ₹21.1 to ₹33.5, shows it has room to run if this breakout sustains, but also highlights the stock’s volatility and the risk of a pullback.
Snapshot: ₹23.09 on 2026-08-17 (chart frozen at publication)
Fundamentals & business context
On the fundamental side, Renuka Sugars presents a mixed picture. With a revenue CAGR of 10.0% over the past five years but no profit CAGR, the company’s PE is not applicable, reflecting its current thin profit margins of -8.4%. This suggests the market may be pricing in a potential turnaround, though the current valuation appears stretched relative to earnings. Institutional ownership stands at 8.9%, indicating a cautious approach by smart money, likely due to the company’s recent quarterly loss and low profit margins. There was no NSE catalyst today, making this move primarily technical in nature.
Algorithmic scorecard
The algorithmic scorecard paints a picture of a stock with technical strength but fundamental weaknesses. The bullish sentiment over the last 30 days, with a higher average volume on up days compared to down days, suggests systematic accumulation. However, the stock’s low profit margin and recent quarterly loss are significant risks, indicating potential vulnerabilities in the company’s financial health. The stock’s position near the lower end of its 52-week range also suggests that while there’s room for growth, the stock is not without its risks.
Get all details on RENUKA — P&L, peers, shareholding and more on TradeAlone.
Confectioners
Triveni Engineering & Industries Limited (TRIVENI) rises 5% intraday
Triveni Engineering & Industries Limited (NSE: TRIVENI) stock moves up 5% intraday to ₹282.16, showing a consolidating down trend despite gains..
Triveni Engineering & Industries Limited (TRIVENI) climbed +5% to ₹282.16 on the NSE on 17 Aug 2026. The stock is consolidating down, approaching resistance but has not cleared it, and remains 27% below its 50-DMA. This move appears to be driven by positive sentiment around the company’s recent NSE filing and management’s optimistic outlook for the upcoming quarters. TRIVENI, a key player in the confectioners segment of the consumer defensive sector, saw its stock rise despite the sector not showing significant momentum, indicating a company-specific catalyst.
Technical setup — trendlines & DMA
The current 6M trendline structure for TRIVENI shows a breakdown, with the stock now consolidating down. The 6M support trendline is at ₹249.18, which is 11.69% below today’s price, while the resistance trendline is at ₹493.77, significantly above the current price by 75.00%. The stock is 27.39% below its 50-DMA and 28.50% below its 200-DMA, indicating a weak position relative to these moving averages. In the 52W range of ₹220.1 to ₹490.1, the stock is in the lower third, suggesting that while there is some recovery from the 52W low, a substantial portion of the move is still priced in.
Snapshot: ₹282.16 on 2026-08-17 (chart frozen at publication)
Fundamentals & business context
With a PE of 21.0, profit margins of 4.3%, and a revenue CAGR of 4.1%, TRIVENI’s valuation appears stretched relative to its current earnings, especially given the declining profit CAGR of -46.9% over the past 5 years. The 10.0% institutional ownership suggests that while there is some interest from smart money, it is not overwhelmingly positive. There was no specific NSE catalyst today beyond the routine filing, indicating that the move may be more sentiment-driven than news-driven.
Algorithmic scorecard
The overall algorithmic scorecard for TRIVENI reflects a technically weak but fundamentally balanced position. Two of the strongest signals are the moderate dividend yield of 2.17%, offering some income benefit, and the good business stability with only one revenue dip in history, indicating strong underlying fundamentals. On the weaker side, the -46.9% profit CAGR over 5 years and the thin profit margin of 4.3% represent significant risks, especially in a sector where cost pressures could further squeeze profitability. The stock’s position near yearly lows and the bearish trend indicated by the 50-DMA below the 200-DMA also suggest caution for investors.
Company outlook
Management’s forward guidance for TRIVENI is cautiously optimistic. They anticipate a good Q2 and a significantly better operating season in Q3 and Q4 for the sugar season 2026-27, driven by better-than-expected monsoon progress. Despite policy uncertainties, they are keenly anticipating growth in the ethanol sector. On the operational front, the company plans to drive controllable efficiencies and improve cost efficiencies at the sugar plants. They are also exploring strategic areas for future Capex, although specific plans are still under examination by the board.
Get all details on TRIVENI — P&L, peers, shareholding and more on TradeAlone.
-
Healthcare2 days agoLupin Limited (lupin) Receives Tentative FDA Approval for Apixaban Oral Suspension
-
Consumer Defensive2 days agoRadico Khaitan Limited Expands Global Reach: Indian Luxury Whisky Brands Land in the Home of Scotch
-
Banks - Regional2 days agoIndusind Bank Limited Launches Dedicated Banking Vertical for India’s Growing Global Capability Centres
-
RATEGAIN2 days agoRategain Travel Technologies Limited (NSE: Rategain) Appoints Chetan Garg as Chief Financial Officer
-
Credit Services2 days agoMoneyboxx Finance Limited (moneyboxx) Raises ₹60 Crore Via Ncds
-
Credit Services2 days agoIndian Railway Finance Corporation Limited Signs Rs 4,200 Crore Loan Agreement with DVC for Renewable Energy Projects
-
Consumer Cyclical2 days agoPatel Retail Limited Opens 54th Store in Kalyan (east)
-
Healthcare2 days agoSun Pharmaceutical Industries Limited (sunpharma) Secures Global Licensing for Lerodalcibep, a PCSK9 Inhibitor
